
Tom Wilbur is Senior Director of Public Affairs at PhRMA focused on opinion research, message development and political communications. Prior to joining PhRMA in 2019, Tom worked on Capitol Hill and on political campaigns for eight years, most recently responsible for communications and strategy for U.S. Rep. Fred Upton and the House Energy and Commerce Committee. Tom is a proud Michigander and outside of the office enjoys spending time with friends and family, reading, running, hiking, and golfing.
Recent Posts
In their own words: Insured Americans support policy reforms that address access and affordability concerns

A survey of more than 5,000 Americans conducted with Ipsos found that insured Americans want better health care coverage. These insights come from the third installment of the Patient Experience...
Read More
In their own words: Financial barriers exacerbate access challenges for insured Americans

A survey of more than 5,000 Americans conducted with Ipsos found that 30% of insured Americans say they face a financial barrier to care, such as unaffordable out-of-pocket costs or a lack of savings...
Read More
In their own words: Insured Americans struggle to navigate complex coverage

A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.
Read More
Polling continues to show voters reject so-called Medicare “negotiation” once they learn about consequences for patients

As policymakers race to pass government price setting policies, it’s important to examine true public sentiment around such proposals. Voters have made clear that they do not support policies such as...
Read More
5 public opinion polling trends to watch

Today, we’re taking a closer look at Americans’ leading concerns and what issues they want policymakers to prioritize.
Read More
Legislation threatens patent protections and future innovation

Recently introduced legislation, the “Restoring the America Invents Act (RAIA),” if enacted, would push the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office to grant more...
Read More
Three things to know about so-called Medicare negotiation polling

As policymakers continue to push partisan drug pricing proposals, several polls misrepresenting voter opinion have been circulated to try and justify these flawed policies. These polls fail to...
Read More
Recent polling misrepresents public support for Medicare “negotiation”

Proponents of government price setting often misrepresent voters’ opinions on support for allowing the federal government to “negotiate” drug prices. This includes recent polling from advocacy firms...
Read More
Myth vs. fact: Polling and Medicare “negotiation”

As some in Washington consider legislation related to prescription medicines and how to best help Americans manage health care costs, government “negotiation” of prescription medicines within...
Read More
Data shows COVID-19 vaccines are creating a pathway to a strong U.S. recovery

As we head into the Fourth of July weekend, Americans are reemerging from the COVID-19 pandemic with heightened hopes and confidence in a strong U.S. recovery. The COVID-19 vaccines have been...
Read More